Cytotoxicity of 11 naturally occurring phenolics and terpenoids from Kenyan flora towards human carcinoma cells

Abstract

Background: Cancer constitutes a major hurdle worldwide and its treatment mainly relies on chemotherapy. Objectives: The present study was designed to evaluate the cytotoxicity of 11 naturally occurring compounds including six phenolics amongst them were 4 chalcones and 2 flavanones as well as 5 terpenoids (3 clerodane and 2 trachylobane diterpenoids) against 6 human carcinoma cell lines and normal CRL2120 fibroblasts. Materials and methods: The neutral red uptake (NR) assay was used to evaluate the cytotoxicity of the compounds, whilst caspase-Glo assay was used to detect caspase activation. Cell cycle and mitochondrial membrane potential (MMP) were all analyzed via flow cytometry meanwhile levels of reactive oxygen species (ROS) was measured by spectrophotometry. Results: Chalcones: 2',4'-dihydroxy-6'-methoxychalcone (1); 4',6'-dihydroxy-2',5'-dimethoxychalcone (2); 2',4',6'-trihydroxy-5'-methoxychalcone (3); 2',6'-diacetate-4'-methoxychalcone (4), trachylobane diterpenoids: 2,6,19-trachylobanetriol; (ent-2?,6?)-form (10) and 2,18,19-trachylobanetriol; (ent-2?)-form (11) as well as doxorubicin displayed IC 50 values below 110 µM in the six tested cancer cell lines. The IC 50 values of the most active compounds were between 6.30 µM and 46.23 µM for compound 1 respectively towards breast adenocarcinoma MCF-7 cells and small lung cancer A549 cells and between 0.07 µM and 1.01 µM for doxorubicin respectively against SPC212 cells and A549 cells. Compounds 1 induced apoptosis in MCF-7 cells mediated by increasing ROS production and MMP loss. Conclusion: Chalcones 1–3 are potential cytotoxic phytochemicals that deserve more investigations to develop novel anticancer drugs against human carcinoma